Philipp Oster

3.3k citations

57 papers · 2.7k indexed · h-index 29

Impact in

Microbiology top 0.05%
- Bacterial Infections and Vaccines
Epidemiology top 1%
- Pneumonia and Respiratory Infections
- Influenza Virus Research Studies
- Virology and Viral Diseases
- Respiratory viral infections research
- Infective Endocarditis Diagnosis and Management

Papers in ⓘ

Microbiology 56
- Bacterial Infections and Vaccines 56
Epidemiology 57
- Pneumonia and Respiratory Infections 53
- Influenza Virus Research Studies 15
- Respiratory viral infections research 12
- Virology and Viral Diseases 11
- Pneumocystis jirovecii pneumonia detection and treatment 3

Co-authors: Jane O’Hallahan (16 shared papers)Diana Martin (15 shared papers)Einar Rosenqvist (6 shared papers)Diana Lennon (11 shared papers)Ellen Ypma (11 shared papers)Johan Holst (2 shared papers)Richard Arnold (2 shared papers)Ray Borrow (9 shared papers)
Journals: Vaccine (10 papers)Clinical and Vaccine Immunology (10 papers)The Pediatric Infectious Disease Journal (7 papers)Human Vaccines & Immunotherapeutics (4 papers)Human Vaccines (3 papers)
Partner nations: New Zealand Italy Norway

In The Last Decade

Philipp Oster

54 papers receiving 2.6k citations

Peers

Countries citing papers authored by Philipp Oster

Since Specialization

Citations

This map shows the geographic impact of Philipp Oster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Oster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Oster more than expected).

Fields of papers citing papers by Philipp Oster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Oster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Oster. The network helps show where Philipp Oster may publish in the future.

Co-authors

The 25 scholars most cited alongside Philipp Oster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philipp Oster Line = papers co-authored together Philipp Oster links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis Vaccine ·Johan Holst, Diana Martin, Richard Arnold, Concepción Campa Huergo, Philipp Oster, Jane O’Hallahan, Einar Rosenqvist	2009	310
2	Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy Clinical Infectious Diseases ·Jamie Findlow, Ray Borrow, Matthew D. Snape, Tom Dawson, Ann Holland, Tessa M. John, A. E. J. Evans, Karen L. Telford, Ellen Ypma, Daniela Toneatto, Philipp Oster, Elizabeth Miller, Andrew J. Pollard	2010	226
3	MeNZB?: a safe and highly immunogenic tailor-made vaccine against the New Zealand serogroup B disease epidemic strain Vaccine ·Philipp Oster, Diana Lennon, Jane O’Hallahan, Kim Mulholland, S Reid, D.J. Martin	2005	224
4	Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future Human Vaccines & Immunotherapeutics ·Johan Holst, Philipp Oster, Richard Arnold, Michael Tatley, Lisbeth Meyer Næss, Ingeborg S. Aaberge, Yvonne Galloway, Anne McNicholas, Jane O’Hallahan, Einar Rosenqvist, Stephen T. Black	2013	175
5	Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life The Pediatric Infectious Disease Journal ·Matthew D. Snape, Tom Dawson, Philipp Oster, A. E. J. Evans, Tessa M. John, Brigitte Ohene-Kena, Jamie Findlow, Ly‐Mee Yu, Ray Borrow, Ellen Ypma, Daniela Toneatto, Andrew J. Pollard	2010	159
6	The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZB Clinical and Vaccine Immunology ·Diana Martin, N. Ruijne, Lisa McCallum, Jane O’Hallahan, Philipp Oster	2006	93
7	Characterization of fHbp , nhba ( gna2132 ), nadA , porA , and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine Clinical and Vaccine Immunology ·Jay Lucidarme, Maurizio Comanducci, Jamie Findlow, Stephen J. Gray, Edward B. Kaczmarski, Malcolm Guiver, Pamela Vallely, Philipp Oster, Mariagrazia Pizza, Stefania Bambini, Alessandro Muzzi, Ray Borrow	2010	90
8	Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus Vaccine ·Marzia Monica Giuliani, Alessia Biolchi, Davide Serruto, Francesca Ferlicca, Kay Vienken, Philipp Oster, Rino Rappuoli, Mariagrazia Pizza, John Donnelly	2010	84
9	Interlaboratory Standardization of the Measurement of Serum Bactericidal Activity by Using Human Complement against Meningococcal Serogroup B, Strain 44/76-SL, before and after Vaccination with the Norwegian MenBvac Outer Membrane Vesicle Vaccine Clinical and Vaccine Immunology ·Ray Borrow, Ingeborg S. Aaberge, George França dos Santos, T. Lynn Eudey, Philipp Oster, Anne Glennie, Jamie Findlow, E. Arne Høiby, Einar Rosenqvist, Paul Balmer, Diana Martin	2005	81
10	The concept of ?tailor-made?, protein-based, outer membrane vesicle vaccines against meningococcal disease Vaccine ·J HOLST, Berit Feiring, L NASS, Gunnstein Norheim, Paul A. Kristiansen, E. Arne Høiby, Klaus Bryn, Philipp Oster, Paolo Costantino, M. P. M. Taha	2005	78
11	Patterns of Macrolide Resistance Determinants among Community-Acquired Streptococcus pneumoniae Isolates over a 5-Year Period of Decreased Macrolide Susceptibility Rates Antimicrobial Agents and Chemotherapy ·Philipp Oster, Alessandra Zanchi, Stefania Cresti, Maria Lattanzi, Francesca Montagnani, C Cellesi, Gian María Rossolini	1999	78
12	The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans Human Vaccines ·Daniela Toneatto, Shevqet Ismaili, Ellen Ypma, Kay Vienken, Philipp Oster, Peter Dull	2011	71
13	Safety review: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease Vaccine ·Hanne Nøkleby, Preben Aavitsland, Jane O’Hallahan, Berit Feiring, Sandrine Tilman, Philipp Oster	2007	69
14	Characterization of fHbp , nhba ( gna2132 ), nadA , porA , Sequence Type (ST), and Genomic Presence of IS 1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales Journal of Clinical Microbiology ·Jay Lucidarme, Maurizio Comanducci, Jamie Findlow, Stephen J. Gray, Edward B. Kaczmarski, Malcolm Guiver, Elisabeth Kugelberg, Pamela Vallely, Philipp Oster, Mariagrazia Pizza, Stefania Bambini, Alessandro Muzzi, Christoph M. Tang, Ray Borrow	2009	66
15	Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand Vaccine ·Philipp Oster, Jane O’Hallahan, Ingeborg S. Aaberge, Sandrine Tilman, Ellen Ypma, Diana Martin	2007	62
16	Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: Beginning of epidemic control Vaccine ·V THORNTON, Diana Lennon, Kumanan Rasanathan, Jane O’Hallahan, Philipp Oster, Joanna Stewart, Sandrine Tilman, Ingeborg S. Aaberge, Berit Feiring, Hanne Nøkleby	2005	58
17	Immunogenicity and Safety of a Combination of Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines Clinical and Vaccine Immunology ·Synne Sandbu, Berit Feiring, Philipp Oster, Oddveig S. Helland, Hilde Bakke, Lisbeth Meyer Næss, Audun Aase, Ingeborg S. Aaberge, Anne-Cathrine Kristoffersen, Kjersti Margrethe Rydland, Sandrine Tilman, Hanne Nøkleby, Einar Rosenqvist	2007	49
18	Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac Infection and Immunity ·Jamie Findlow, Stephen Taylor, Audun Aase, Rachel Horton, Robert S. Heyderman, Jo Southern, Nick Andrews, Rita Barchha, Ewan M. Harrison, Ann Lowe, Emma Boxer, Charlotte Heaton, Paul Balmer, Ed Kaczmarski, Philipp Oster, Andrew Gorringe, Ray Borrow, Elizabeth Miller	2006	48
19	Functional and Specific Antibody Responses in Adult Volunteers in New Zealand Who Were Given One of Two Different Meningococcal Serogroup B Outer Membrane Vesicle Vaccines Clinical and Vaccine Immunology ·Elisabeth Wedege, Karin Bolstad, Audun Aase, Tove Karin Herstad, Lisa McCallum, Einar Rosenqvist, Philipp Oster, Diana Martin	2007	48
20	Persisting Immune Responses Indicating Long-Term Protection after Booster Dose with Meningococcal Group B Outer Membrane Vesicle Vaccine Clinical and Vaccine Immunology ·Berit Feiring, J. E. Fuglesang, Philipp Oster, Lisbeth Meyer Næss, Oddveig S. Helland, Sandrine Tilman, Einar Rosenqvist, Marianne A. Riise Bergsaker, Hanne Nøkleby, Ingeborg S. Aaberge	2006	43

About Philipp Oster

Philipp Oster is a scholar working on Microbiology, Epidemiology, Health, Rheumatology and Endocrinology, having authored 57 papers that have together received 2.7k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (56 papers), Pneumonia and Respiratory Infections (53 papers), Influenza Virus Research Studies (15 papers), Respiratory viral infections research (12 papers), Virology and Viral Diseases (11 papers), Cystic Fibrosis Research Advances (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and IgG4-Related and Inflammatory Diseases (3 papers). The work is most often cited by research in Microbiology (2.4k citations), Epidemiology (2.3k citations), Endocrinology (165 citations), Immunology (265 citations) and Infectious Diseases (219 citations). Philipp Oster has collaborated with scholars based in New Zealand, Italy and Norway. Frequent co-authors include Jane O’Hallahan, Diana Martin, Einar Rosenqvist, Diana Lennon, Ellen Ypma, Johan Holst, Richard Arnold, Ray Borrow, Ingeborg S. Aaberge and Jamie Findlow. Their work appears in journals such as Vaccine, Clinical and Vaccine Immunology, The Pediatric Infectious Disease Journal, Human Vaccines & Immunotherapeutics and Human Vaccines.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact